0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Glyburide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-23C7989
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glyburide Market Insights Forecast to 2028
BUY CHAPTERS

Glyburide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-23C7989
Report
November 2024
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Glyburide - Market Size

The global market for Glyburide was estimated to be worth US$ 1536 million in 2023 and is forecast to a readjusted size of US$ 2272.1 million by 2030 with a CAGR of 5.8% during the forecast period 2024-2030

Glyburide - Market

Glyburide - Market

Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II. It is typically given to patients who cannot be managed with the standard first line therapy, metformin. Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glyburide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glyburide by region & country, by Type, and by Application.
The Glyburide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glyburide.
Market Segmentation

Scope of Glyburide - Market Report

Report Metric Details
Report Name Glyburide - Market
Forecasted market size in 2030 US$ 2272.1 million
CAGR 5.8%
Forecasted years 2024 - 2030
Segment by Type:
  • 1.25mg
  • 2.5mg
  • 5mg
Segment by Application
  • Pediatric Use
  • Geriatric Use
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu, Physicians Total Care, Hoechst Canada, Apotex Corporation, Avanstra, Dominion Pharmacal, Hikma Pharmaceuticals, Cadila Pharmaceuticals, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Glyburide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Glyburide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Glyburide in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Glyburide - Market size in 2030?

Ans: The Glyburide - Market size in 2030 will be US$ 2272.1 million.

Who are the main players in the Glyburide - Market report?

Ans: The main players in the Glyburide - Market are Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu, Physicians Total Care, Hoechst Canada, Apotex Corporation, Avanstra, Dominion Pharmacal, Hikma Pharmaceuticals, Cadila Pharmaceuticals, Novartis

What are the Application segmentation covered in the Glyburide - Market report?

Ans: The Applications covered in the Glyburide - Market report are Pediatric Use, Geriatric Use, Others

What are the Type segmentation covered in the Glyburide - Market report?

Ans: The Types covered in the Glyburide - Market report are 1.25mg, 2.5mg, 5mg

1 Market Overview
1.1 Glyburide Product Introduction
1.2 Global Glyburide Market Size Forecast
1.2.1 Global Glyburide Sales Value (2019-2030)
1.2.2 Global Glyburide Sales Volume (2019-2030)
1.2.3 Global Glyburide Sales Price (2019-2030)
1.3 Glyburide Market Trends & Drivers
1.3.1 Glyburide Industry Trends
1.3.2 Glyburide Market Drivers & Opportunity
1.3.3 Glyburide Market Challenges
1.3.4 Glyburide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glyburide Players Revenue Ranking (2023)
2.2 Global Glyburide Revenue by Company (2019-2024)
2.3 Global Glyburide Players Sales Volume Ranking (2023)
2.4 Global Glyburide Sales Volume by Company Players (2019-2024)
2.5 Global Glyburide Average Price by Company (2019-2024)
2.6 Key Manufacturers Glyburide Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Glyburide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Glyburide
2.9 Glyburide Market Competitive Analysis
2.9.1 Glyburide Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Glyburide Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glyburide as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 1.25mg
3.1.2 2.5mg
3.1.3 5mg
3.2 Global Glyburide Sales Value by Type
3.2.1 Global Glyburide Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Glyburide Sales Value, by Type (2019-2030)
3.2.3 Global Glyburide Sales Value, by Type (%) (2019-2030)
3.3 Global Glyburide Sales Volume by Type
3.3.1 Global Glyburide Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Glyburide Sales Volume, by Type (2019-2030)
3.3.3 Global Glyburide Sales Volume, by Type (%) (2019-2030)
3.4 Global Glyburide Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pediatric Use
4.1.2 Geriatric Use
4.1.3 Others
4.2 Global Glyburide Sales Value by Application
4.2.1 Global Glyburide Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Glyburide Sales Value, by Application (2019-2030)
4.2.3 Global Glyburide Sales Value, by Application (%) (2019-2030)
4.3 Global Glyburide Sales Volume by Application
4.3.1 Global Glyburide Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Glyburide Sales Volume, by Application (2019-2030)
4.3.3 Global Glyburide Sales Volume, by Application (%) (2019-2030)
4.4 Global Glyburide Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Glyburide Sales Value by Region
5.1.1 Global Glyburide Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Glyburide Sales Value by Region (2019-2024)
5.1.3 Global Glyburide Sales Value by Region (2025-2030)
5.1.4 Global Glyburide Sales Value by Region (%), (2019-2030)
5.2 Global Glyburide Sales Volume by Region
5.2.1 Global Glyburide Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Glyburide Sales Volume by Region (2019-2024)
5.2.3 Global Glyburide Sales Volume by Region (2025-2030)
5.2.4 Global Glyburide Sales Volume by Region (%), (2019-2030)
5.3 Global Glyburide Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Glyburide Sales Value, 2019-2030
5.4.2 North America Glyburide Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Glyburide Sales Value, 2019-2030
5.5.2 Europe Glyburide Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Glyburide Sales Value, 2019-2030
5.6.2 Asia Pacific Glyburide Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Glyburide Sales Value, 2019-2030
5.7.2 South America Glyburide Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Glyburide Sales Value, 2019-2030
5.8.2 Middle East & Africa Glyburide Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glyburide Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Glyburide Sales Value
6.2.1 Key Countries/Regions Glyburide Sales Value, 2019-2030
6.2.2 Key Countries/Regions Glyburide Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Glyburide Sales Value, 2019-2030
6.3.2 United States Glyburide Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Glyburide Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Glyburide Sales Value, 2019-2030
6.4.2 Europe Glyburide Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Glyburide Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Glyburide Sales Value, 2019-2030
6.5.2 China Glyburide Sales Value by Type (%), 2023 VS 2030
6.5.3 China Glyburide Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Glyburide Sales Value, 2019-2030
6.6.2 Japan Glyburide Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Glyburide Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Glyburide Sales Value, 2019-2030
6.7.2 South Korea Glyburide Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Glyburide Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Glyburide Sales Value, 2019-2030
6.8.2 Southeast Asia Glyburide Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Glyburide Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Glyburide Sales Value, 2019-2030
6.9.2 India Glyburide Sales Value by Type (%), 2023 VS 2030
6.9.3 India Glyburide Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amneal Pharmaceuticals
7.1.1 Amneal Pharmaceuticals Company Information
7.1.2 Amneal Pharmaceuticals Introduction and Business Overview
7.1.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Amneal Pharmaceuticals Glyburide Product Offerings
7.1.5 Amneal Pharmaceuticals Recent Development
7.2 Sanofi Aventis
7.2.1 Sanofi Aventis Company Information
7.2.2 Sanofi Aventis Introduction and Business Overview
7.2.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Sanofi Aventis Glyburide Product Offerings
7.2.5 Sanofi Aventis Recent Development
7.3 Jisheng Medicine
7.3.1 Jisheng Medicine Company Information
7.3.2 Jisheng Medicine Introduction and Business Overview
7.3.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Jisheng Medicine Glyburide Product Offerings
7.3.5 Jisheng Medicine Recent Development
7.4 Double Whale Pharmaceutical
7.4.1 Double Whale Pharmaceutical Company Information
7.4.2 Double Whale Pharmaceutical Introduction and Business Overview
7.4.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Double Whale Pharmaceutical Glyburide Product Offerings
7.4.5 Double Whale Pharmaceutical Recent Development
7.5 Bohai Pharmaceutical
7.5.1 Bohai Pharmaceutical Company Information
7.5.2 Bohai Pharmaceutical Introduction and Business Overview
7.5.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Bohai Pharmaceutical Glyburide Product Offerings
7.5.5 Bohai Pharmaceutical Recent Development
7.6 Sunlight Pharmaceutical
7.6.1 Sunlight Pharmaceutical Company Information
7.6.2 Sunlight Pharmaceutical Introduction and Business Overview
7.6.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Sunlight Pharmaceutical Glyburide Product Offerings
7.6.5 Sunlight Pharmaceutical Recent Development
7.7 Shapuaisi Pharma
7.7.1 Shapuaisi Pharma Company Information
7.7.2 Shapuaisi Pharma Introduction and Business Overview
7.7.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Shapuaisi Pharma Glyburide Product Offerings
7.7.5 Shapuaisi Pharma Recent Development
7.8 CR Sanjiu
7.8.1 CR Sanjiu Company Information
7.8.2 CR Sanjiu Introduction and Business Overview
7.8.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.8.4 CR Sanjiu Glyburide Product Offerings
7.8.5 CR Sanjiu Recent Development
7.9 Physicians Total Care
7.9.1 Physicians Total Care Company Information
7.9.2 Physicians Total Care Introduction and Business Overview
7.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Physicians Total Care Glyburide Product Offerings
7.9.5 Physicians Total Care Recent Development
7.10 Hoechst Canada
7.10.1 Hoechst Canada Company Information
7.10.2 Hoechst Canada Introduction and Business Overview
7.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Hoechst Canada Glyburide Product Offerings
7.10.5 Hoechst Canada Recent Development
7.11 Apotex Corporation
7.11.1 Apotex Corporation Company Information
7.11.2 Apotex Corporation Introduction and Business Overview
7.11.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Apotex Corporation Glyburide Product Offerings
7.11.5 Apotex Corporation Recent Development
7.12 Avanstra
7.12.1 Avanstra Company Information
7.12.2 Avanstra Introduction and Business Overview
7.12.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Avanstra Glyburide Product Offerings
7.12.5 Avanstra Recent Development
7.13 Dominion Pharmacal
7.13.1 Dominion Pharmacal Company Information
7.13.2 Dominion Pharmacal Introduction and Business Overview
7.13.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Dominion Pharmacal Glyburide Product Offerings
7.13.5 Dominion Pharmacal Recent Development
7.14 Hikma Pharmaceuticals
7.14.1 Hikma Pharmaceuticals Company Information
7.14.2 Hikma Pharmaceuticals Introduction and Business Overview
7.14.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Hikma Pharmaceuticals Glyburide Product Offerings
7.14.5 Hikma Pharmaceuticals Recent Development
7.15 Cadila Pharmaceuticals
7.15.1 Cadila Pharmaceuticals Company Information
7.15.2 Cadila Pharmaceuticals Introduction and Business Overview
7.15.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Cadila Pharmaceuticals Glyburide Product Offerings
7.15.5 Cadila Pharmaceuticals Recent Development
7.16 Novartis
7.16.1 Novartis Company Information
7.16.2 Novartis Introduction and Business Overview
7.16.3 Novartis Glyburide Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Novartis Glyburide Product Offerings
7.16.5 Novartis Recent Development
8 Industry Chain Analysis
8.1 Glyburide Industrial Chain
8.2 Glyburide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Glyburide Sales Model
8.5.2 Sales Channel
8.5.3 Glyburide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Glyburide Market Trends
    Table 2. Glyburide Market Drivers & Opportunity
    Table 3. Glyburide Market Challenges
    Table 4. Glyburide Market Restraints
    Table 5. Global Glyburide Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Glyburide Revenue Market Share by Company (2019-2024)
    Table 7. Global Glyburide Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Glyburide Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Glyburide Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Glyburide Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Glyburide Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Glyburide
    Table 13. Global Glyburide Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glyburide as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Glyburide Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Glyburide Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Glyburide Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Glyburide Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Glyburide Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Glyburide Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Glyburide Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Glyburide Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Glyburide Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Glyburide Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Glyburide Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Glyburide Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Glyburide Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Glyburide Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Glyburide Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Glyburide Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Glyburide Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Glyburide Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Glyburide Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Glyburide Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Glyburide Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Glyburide Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Glyburide Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Glyburide Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Glyburide Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Glyburide Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Glyburide Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Glyburide Sales Value by Region (2019-2024) & (%)
    Table 44. Global Glyburide Sales Value by Region (2025-2030) & (%)
    Table 45. Global Glyburide Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Glyburide Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Glyburide Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Glyburide Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Glyburide Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Glyburide Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Glyburide Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Glyburide Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Glyburide Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Glyburide Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Glyburide Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Glyburide Sales Volume, (2025-2030) & (K Units)
    Table 57. Amneal Pharmaceuticals Company Information
    Table 58. Amneal Pharmaceuticals Introduction and Business Overview
    Table 59. Amneal Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Amneal Pharmaceuticals Glyburide Product Offerings
    Table 61. Amneal Pharmaceuticals Recent Development
    Table 62. Sanofi Aventis Company Information
    Table 63. Sanofi Aventis Introduction and Business Overview
    Table 64. Sanofi Aventis Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Sanofi Aventis Glyburide Product Offerings
    Table 66. Sanofi Aventis Recent Development
    Table 67. Jisheng Medicine Company Information
    Table 68. Jisheng Medicine Introduction and Business Overview
    Table 69. Jisheng Medicine Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Jisheng Medicine Glyburide Product Offerings
    Table 71. Jisheng Medicine Recent Development
    Table 72. Double Whale Pharmaceutical Company Information
    Table 73. Double Whale Pharmaceutical Introduction and Business Overview
    Table 74. Double Whale Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Double Whale Pharmaceutical Glyburide Product Offerings
    Table 76. Double Whale Pharmaceutical Recent Development
    Table 77. Bohai Pharmaceutical Company Information
    Table 78. Bohai Pharmaceutical Introduction and Business Overview
    Table 79. Bohai Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Bohai Pharmaceutical Glyburide Product Offerings
    Table 81. Bohai Pharmaceutical Recent Development
    Table 82. Sunlight Pharmaceutical Company Information
    Table 83. Sunlight Pharmaceutical Introduction and Business Overview
    Table 84. Sunlight Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Sunlight Pharmaceutical Glyburide Product Offerings
    Table 86. Sunlight Pharmaceutical Recent Development
    Table 87. Shapuaisi Pharma Company Information
    Table 88. Shapuaisi Pharma Introduction and Business Overview
    Table 89. Shapuaisi Pharma Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Shapuaisi Pharma Glyburide Product Offerings
    Table 91. Shapuaisi Pharma Recent Development
    Table 92. CR Sanjiu Company Information
    Table 93. CR Sanjiu Introduction and Business Overview
    Table 94. CR Sanjiu Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. CR Sanjiu Glyburide Product Offerings
    Table 96. CR Sanjiu Recent Development
    Table 97. Physicians Total Care Company Information
    Table 98. Physicians Total Care Introduction and Business Overview
    Table 99. Physicians Total Care Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Physicians Total Care Glyburide Product Offerings
    Table 101. Physicians Total Care Recent Development
    Table 102. Hoechst Canada Company Information
    Table 103. Hoechst Canada Introduction and Business Overview
    Table 104. Hoechst Canada Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Hoechst Canada Glyburide Product Offerings
    Table 106. Hoechst Canada Recent Development
    Table 107. Apotex Corporation Company Information
    Table 108. Apotex Corporation Introduction and Business Overview
    Table 109. Apotex Corporation Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Apotex Corporation Glyburide Product Offerings
    Table 111. Apotex Corporation Recent Development
    Table 112. Avanstra Company Information
    Table 113. Avanstra Introduction and Business Overview
    Table 114. Avanstra Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Avanstra Glyburide Product Offerings
    Table 116. Avanstra Recent Development
    Table 117. Dominion Pharmacal Company Information
    Table 118. Dominion Pharmacal Introduction and Business Overview
    Table 119. Dominion Pharmacal Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Dominion Pharmacal Glyburide Product Offerings
    Table 121. Dominion Pharmacal Recent Development
    Table 122. Hikma Pharmaceuticals Company Information
    Table 123. Hikma Pharmaceuticals Introduction and Business Overview
    Table 124. Hikma Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Hikma Pharmaceuticals Glyburide Product Offerings
    Table 126. Hikma Pharmaceuticals Recent Development
    Table 127. Cadila Pharmaceuticals Company Information
    Table 128. Cadila Pharmaceuticals Introduction and Business Overview
    Table 129. Cadila Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 130. Cadila Pharmaceuticals Glyburide Product Offerings
    Table 131. Cadila Pharmaceuticals Recent Development
    Table 132. Novartis Company Information
    Table 133. Novartis Introduction and Business Overview
    Table 134. Novartis Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 135. Novartis Glyburide Product Offerings
    Table 136. Novartis Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Glyburide Downstream Customers
    Table 140. Glyburide Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Glyburide Product Picture
    Figure 2. Global Glyburide Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Glyburide Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Glyburide Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Glyburide Report Years Considered
    Figure 7. Global Glyburide Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Glyburide Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Glyburide Revenue in 2023
    Figure 10. Glyburide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. 1.25mg Picture
    Figure 12. 2.5mg Picture
    Figure 13. 5mg Picture
    Figure 14. Global Glyburide Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Glyburide Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Glyburide Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 17. Global Glyburide Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Glyburide Price by Type (2019-2030) & (US$/Unit)
    Figure 19. Product Picture of Pediatric Use
    Figure 20. Product Picture of Geriatric Use
    Figure 21. Product Picture of Others
    Figure 22. Global Glyburide Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Glyburide Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Glyburide Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Glyburide Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Glyburide Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Glyburide Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Glyburide Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Glyburide Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Glyburide Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Glyburide Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Glyburide Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Glyburide Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Glyburide Sales Volume (%), (2019-2030)
    Figure 39. United States Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Glyburide Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Glyburide Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Glyburide Sales Value by Application (%), 2023 VS 2030
    Figure 60. Glyburide Industrial Chain
    Figure 61. Glyburide Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS